Enhanced drug delivery to melanoma cells using PMPC-PDPA polymersomes

Cancer Letters

Volumn 334, Issue 2, 2013, Pages 328-337

  Pegoraro, Carla ^a   Cecchin, Denis ^a   Gracia, Lorena Simon ^a,b   Warren, Nicholas ^a   Madsen, Jeppe ^a   Armes, Steven P ^a   Lewis, Andrew ^c   MacNeil, Sheila ^a   Battaglia, Giuseppe ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF BARCELONA   (Spain)

^c BIOCOMPATIBLES UK LTD   (United Kingdom)

Author keywords

Doxorubicin; Melanoma; Polymersomes; Targeted delivery

Indexed keywords

COPOLYMER; DOXORUBICIN; METHACRYLOYLOXYETHYLPHOSPHORYLCHOLINE 2 (DIISOPROPYLAMINO)ETHYL METHACRYLATE COPOLYMER; UNCLASSIFIED DRUG;

ARTICLE; ATOM TRANSFER RADICAL POLYMERIZATION; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTERNALIZATION; LIGHT SCATTERING; MELANOMA CELL; PH; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ANTIBIOTICS, ANTINEOPLASTIC; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FIBROBLASTS; HUMANS; MELANOMA; METHACRYLATES; PHOSPHORYLCHOLINE; POLYMERS; POLYMETHACRYLIC ACIDS;

EID: 84878246005     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.02.007     Document Type: Article

References (46)

1. Smart T., Lomas H., Massignani M., Flores-Merino M.V., Perez L.R., Battaglia G. Block copolymer nanostructures. Nano Today 2008, 3:38-46.
2. Miyata K., Nishiyama N., Kataoka K. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. Chem. Soc. Rev. 2012, 41:2562-2574.
3. Kataoka K., Harada A., Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Delivery Rev. 2001, 47:113-131.
4. Massignani M., LoPresti C., Blanazs A., Madsen J., Armes S.P., Lewis A.L., Battaglia G. Controlling cellular uptake by surface chemistry, size, and surface topology at the nanoscale. Small 2009, 5:2424-2432.
5. Peer D., Karp J.M., Hong S., FaroKHzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2:751-760.
6. Levine D.H., Ghoroghchian P.P., Freudenberg J., Zhang G., Therien M.J., Greene M.I., Hammer D.A., Murali R. Polymersomes: a new multi-functional tool for cancer diagnosis and therapy. Methods 2008, 46:25-32.
7. LoPresti C., Massignani M., Fernyhough C., Blanazs A., Ryan A.J., Madsen J., Warren N.J., Armes S.P., Lewis A.L., Chirasatitsin S., Engler A.J., Battaglia G. Controlling polymersome surface topology at the nanoscale by membrane confined polymer/polymer phase separation. ACS Nano. 2011, 5:1775-1784.
8. Tanford C. The hydrophobic effect and the organization of living matter. Science 1978, 200:1012-1018.
9. Pratt L.R. Theory of hydrophobic effects. Annu. Rev. Phys. Chem. 1985, 36:433-449.
10. Discher D.E., Ahmed F. Polymersomes. Annu. Rev. Biomed. Eng. 2006, 8:323-341.
11. Discher D.E., Ortiz V., Srinivas G., Klein M.L., Kim Y., David C.A., Cai S.S., Photos P., Ahmed F. Emerging applications of polymersomes in delivery: from molecular dynamics to shrinkage of tumors. Prog. Polym. Sci. 2007, 32:838-857.
12. Egli S., Nussbaumer M.G., Balasubramanian V., Chami M., Bruns N., Palivan C., Meier W. Biocompatible functionalization of polymersome surfaces: a new approach to surface immobilization and cell targeting using polymersomes. J. Am. Chem. Soc. 2011, 133:4476-4483.
13. Brinkhuis R.P., Rutjes F.P.J.T., van Hest J.C.M. Polymeric vesicles in biomedical applications. Polym Chem - UK 2011, 2:1449-1462.
14. LoPresti C., Lomas H., Massignani M., Smart T., Battaglia G. Polymersomes: nature inspired nanometer sized compartments. J. Mater. Chem. 2009, 19:3576-3590.
15. Discher D.E., Eisenberg A. Polymer vesicles. Science 2002, 297:967-973.
16. Battaglia G., Ryan A.J., Tomas S. Polymeric vesicle permeability: a facile chemical assay. Langmuir 2006, 22:4910-4913.
17. Discher B.M., Won Y.Y., Ege D.S., Lee J.C.M., Bates F.S., Discher D.E., Hammer D.A. Polymersomes: tough vesicles made from diblock copolymers. Science 1999, 284:1143-1146.
18. Xiong X.B., Mahmud A., Uludag H., Lavasanifar A. Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells. Pharm. Res. 2008, 25:2555-2566.
19. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy (vol. 56, pg. 1649, 2004). Adv. Drug Delivery Rev. 2009, 61. 364-364.
20. Xiong X.B., Huang Y., Lu W.L., Zhang X., Zhang H., Nagai T., Zhang Q. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J. Control. Release 2005, 107:262-275.
21. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Delivery Rev. 2004, 56:1649-1659.
22. Shi M., Shoichet M.S. Furan-functionalized co-polymers for targeted drug delivery: characterization, self-assembly and drug encapsulation. J. Biomater. Sci., Polym. Ed. 2008, 19:1143-1157.
23. Wong H.L., Rauth A.M., Bendayan R., Manias J.L., Ramaswamy M., Liu Z.S., Erhan S.Z., Wu X.Y. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm. Res. 2006, 23:1574-1585.
24. Janes K.A., Fresneau M.P., Marazuela A., Fabra A., Alonso M.J. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release 2001, 73:255-267.
25. Mitra S., Gaur U., Ghosh P.C., Maitra A.N. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J. Control. Release 2001, 74:317-323.
26. Lai P.S., Lou P.J., Peng C.L., Pai C.L., Yen W.N., Huang M.Y., Young T.H., Shieh M.J. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. J. Control. Release 2007, 122:39-46.
27. Shi M., Ho K., Keating A., Shoichet M.S. Doxorubicin-conjugated immuno-nanoparticles for intracellular anticancer drug delivery. Adv. Funct. Mater. 2009, 19:1689-1696.
28. Goren D., Horowitz A.T., Tzemach D., Tarshish M., Zalipsky S., Gabizon A. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin. Cancer Res. 2000, 6:1949-1957.
29. Gai S.L., Yang P.P., Ma P.A., Wang D., Li C.X., Li X.B., Niu N., Lin J. Fibrous-structured magnetic and mesoporous Fe(3)O(4)/silica microspheres: synthesis and intracellular doxorubicin delivery. J. Mater. Chem. 2011, 21:16420-16426.
30. Shen L., Du J.Z., Armes S.P., Liu S.Y. Kinetics of pH-induced formation and dissociation of polymeric vesicles assembled from a water-soluble zwitterionic diblock copolymer. Langmuir 2008, 24:10019-10025.
31. Lomas H., Massignani M., Abdullah K.A., Canton I., Lo Presti C., MacNeil S., Du J.Z., Blanazs A., Madsen J., Armes S.P., Lewis A.L., Battaglia G. Non-cytotoxic polymer vesicles for rapid and efficient intracellular delivery. Faraday Discuss. 2008, 139:143-159.
32. Lomas H., Du J.Z., Canton I., Madsen J., Warren N., Armes S.P., Lewis A.L., Battaglia G. Efficient encapsulation of plasmid DNA in pH-sensitive PMPC-PDPA polymersomes: study of the effect of PDPA block length on copolymer-DNA binding affinity. Macromol. Biosci. 2010, 10:513-530.
33. Massignani M., Lomas H., Battaglia G. Polymersomes: a synthetic biological approach to encapsulation and delivery. Adv. Polym. Sci. 2010, 229:115-154.
34. Lomas H., Canton I., MacNeil S., Du J., Armes S.P., Ryan A.J., Lewis A.L., Battaglia G. Biomimetic pH sensitive polymersomes for efficient DNA encapsulation and delivery. Adv. Mater. 2007, 19:4238-4243.
35. I. Canton, L. Chierico, Fully synthetic polymer vesicles for intracellular delivery of antibodies in live cells, FASEB J, in press.
36. Sanson C., Schatz C., Le Meins J.F., Soum A., Thevenot J., Garanger E., Lecommandoux S. A simple method to achieve high doxorubicin loading in biodegradable polymersomes. J. Control. Release 2010, 147:428-435.
37. Wada R., Hyon S.H., Ikada Y. Lactic-acid oligomer microspheres containing hydrophilic drugs. J. Pharm. Sci. 1990, 79:919-924.
38. Du J.Z., Tang Y.P., Lewis A.L., Armes S.P. pH-sensitive vesicles based on a biocompatible zwitterionic diblock copolymer. J. Am. Chem. Soc. 2005, 127:17982-17983.
39. L. Wang, L. Chierico, D. Little, N. Patikarnmonthon, M. Azzouz, J. Madsen, S.P. Armes, G. Battaglia, Encapsulation of biomacromolecules within polymersomes via electroporation, Angew. Chem. Int. Ed., in press.
40. Massignani M., Canton I., Sun T., Hearnden V., MacNeil S., Blanazs A., Armes S.P., Lewis A., Battaglia G. Enhanced fluorescence imaging of live cells by effective cytosolic delivery of probes. Plos One 2010, 5.
41. Skovsgaard T., Nissen N.I. Membrane-transport of anthracyclines. Pharmacol. Therapeut. 1982, 18:293-311.
42. Kiyomiya K., Matsuo S., Kurebe M. Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin-proteasome complex. Cancer Res. 2001, 61:2467-2471.
43. Kiyomiya K., Matsuo S., Kurebe M. Proteasome is a carrier to translocate doxorubicin from cytoplasm into nucleus. Life Sci. 1998, 62:1853-1860.
44. Shen F., Chu S., Bence A.K., Bailey B., Xue X., Erickson P.A., Montrose M.H., Beck W.T., Erickson L.C. Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. J. Pharmacol. Exp. Ther. 2008, 324:95-102.
45. Gabizon A., Catane R., Uziely B., Kaufman B., Safra T., Cohen R., Martin F., Huang A., Barenholz Y. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsualted in polyethylene-glycol coated liposomes. Cancer Res. 1994, 54:987-992.
46. Sanson C., Schatz C., Le Meins J.-F., Soum A., Thevenor J., Garanger E., Lecommandoux S. A simple method to achieve high doxorubicin loading in biodegradable polymersomes. J. Control. Release 2010, 147:428-435.